JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY
Online ISSN : 1884-5746
Print ISSN : 1884-9938
Original
Feasibility of endoscopic radical and modified radical hysterectomy combined with pelvic lymphadenectomy
Masayoshi Hosaka, Masataka Kudo, Daisuke Akashi, Takashi Mitamura, Tatsuya Kato, Masashi Moriwaki, Satoko Sudo, Mahito Takeda, Yasuhiko Ebina, Hidemichi Watari, Yoshinori Kaneuchi, Noriaki Sakuragi
Author information
JOURNAL FREE ACCESS

2009 Volume 25 Issue 2 Pages 432-437

Details
Abstract
Objectives: The purpose of this study was to determine the feasibility and radicality of endoscopic radical hysterectomy (ERH) and endoscopic modified radical hysterectomy (EmRH) combined with pelvic lymphadenectomy (ELND) in invasive cervical cancer patients.
Methods: Five patients with invasive cervical cancer underwent ERH or EmRH between May 2003 and March 2007 at Hokkaido University Hospital. Two patients with stage I a adenocarcinoma underwent an EmRH, and two patients with stage I b1 and one patient with stage II a underwent an ERH. All patients gave their informed consent to this experimental procedure before surgery.
Results: The median age of patients was 39 years (range, 33-45 years), and the median body mass index was 20.2 kg/m2 (range, 18.5-23.7 kg/m2). The maximum tumor diameter was 20mm in 1 patient, and ≤10mm in 4 patients. The pathologic subtype was squamous cell carcinoma in 2 patients, and adenocarcinoma in 3 patients. The median operative time was 734 min (range, 583-974 min), the median blood loss was 890 ml(range, 280-2650 ml), the median number of lymph nodes removed was 77 (range, 47-103), and the median length of vaginal cuff removed was 20mm(range, 10-25mm). The median duration of hospitalization post-operatively was 16 days (range, 13-23 days). A post-surgical infection occurred in one patient, but no severe complications were noted. There were no relapses after a mean follow-up period of 31.8 months (range, 15-71 months).
Conclusions: An ERH or EmRH with ELND is feasible and might be beneficial for early invasive cervical cancer.
Content from these authors
© 2009 Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
Previous article Next article
feedback
Top